The Romanian Competition Authority fines a pharmaceutical company for non-compliance with some of its remedial commitments agreed off the back of an investigation regarding possible abuse of dominant position (GlaxoSmithKline)

The Competition Council Sanctioned Glaxosmithkline Srl With Fine of 11.9 Million Lei* The Competition Council sanctioned GlaxoSmithKline (GSK) SRL with fine of lei 11.9 million for non-compliance with some of its commitments assumed during the investigation regarding a possible abuse of dominant position. In

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Romanian Competition Authority, The Romanian Competition Authority fines a pharmaceutical company for non-compliance with some of its remedial commitments agreed off the back of an investigation regarding possible abuse of dominant position (GlaxoSmithKline), 25 August 2020, e-Competitions Remedies for unilateral conduct, Art. N° 96608

Visites 873

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues